Ludwig Boltzmann Institute
Applied Diagnostics

Welcome
The Ludwig Boltzmann Institute Applied Diagnostics (lbi:ad) is a translational research institution of the Ludwig Boltzmann Gesellschaft with the aim of combining a team of transdisciplinary scientists, academic and industrial partners from several countries.
We follow a new dual biomarker concept for tumor diagnosis. The focus of the institute lies on the development of minimal-invasive diagnostic methods linking molecular epigenetic and genetic signatures with molecular imaging biomarkers for PET and SPECT analysis. The combination of these two methods will allow for improved functional, spatial and temporal assessment of tumor load and molecular tumor characterization.
If you like to support our research, donations are very welcome. For bank details, please send us a short request.
News
-
New review article from the “Health Economics” program line
A new review study using meta-analysis and a systematic literature review to evaluate the volume–…
LBI for Applied Diagnostics
23 Feb 2023 -
PATIO beim OIS zam Forum 2022
Erstes Forum für Projekte, bei denen Forschende gemeinsam mit Betroffenen Fragen rund um Gesundhe…
LBI for Applied Diagnostics
03 Jan 2023
-
Markus Zeitlinger im Interview
Experten-Warnung vor Gefahren für klinische Forschung in Österreich
LBI for Applied Diagnostics
16 Dec 2022
-
New review article from the “Health Economics” program line
A new review study using meta-analysis and a systematic literature review to evaluate the volume–…
LBI for Applied Diagnostics
23 Feb 2023 -
PATIO beim OIS zam Forum 2022
Erstes Forum für Projekte, bei denen Forschende gemeinsam mit Betroffenen Fragen rund um Gesundhe…
LBI for Applied Diagnostics
03 Jan 2023 -
Markus Zeitlinger im Interview
Experten-Warnung vor Gefahren für klinische Forschung in Österreich
LBI for Applied Diagnostics
16 Dec 2022